IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Deep Track Capital, LP

Q1 2024 Holdings

Filed 2024-05-15 | 66 holdings | $3.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Springworks Therapeutics IncCOM85205L107$171.3M3,479,8534.9%
Amgen Inc(AMGN)COM031162100$156.4M550,0004.5%
Apogee Therapeutics Inc(APGE)COM03770N101$154.4M2,323,4564.4%
Insmed Inc(INSM)COM PAR $.01457669307$129.8M4,783,6793.7%
Dyne Therapeutics Inc(DYN)COM26818M108$129.3M4,555,3833.7%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$124.4M832,3103.6%
Guardant Health Inc(GH)COM40131M109$123.8M6,000,0003.5%
Argenx SE(ARGX)SPONSORED ADR04016X101$118.1M300,0003.4%
Intellia Therapeutics Inc(NTLA)COM45826J105$115.8M4,210,7843.3%
Ocular Therapeutix Inc(OCUL)COM67576A100$115.8M12,721,4603.3%
Dynavax Technologies Corp(DVAX)COM NEW268158201$113.4M9,141,6603.2%
Axsome Therapeutics Inc(AXSM)COM05464T104$104.1M1,304,7213.0%
Intra-Cellular Therapies Inc(ITCIEUR)COM46116X101$103.8M1,500,0003.0%
Geron Corp(GERN)COM374163103$100.7M30,505,9292.9%
Autolus Therapeutics PLC(AUTL)SPON ADS05280R100$97.4M15,272,1722.8%
4D Molecular Therapeutics in(FDMT)COM35104E100$96.7M3,034,4532.8%
Alkermes PLC(ALKS)SHSG01767105$94.7M3,500,0002.7%
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$86.9M3,490,5062.5%
Pliant Therapeutics Inc(PLRX)COM729139105$85.7M5,750,0002.5%
Mind Medicine Mindmed Inc(BRD1EUR)COM NEW60255C885$62.7M6,666,6671.8%
Abivax SA(ABVX)SPONSORED ADS00370M103$61.5M4,297,4381.8%
Viridian Therapeutics Inc(VRDN)COM92790C104$60.5M3,456,0531.7%
Ionis Pharmaceuticals Inc(IONS)COM462222100$59.5M1,373,4751.7%
Apellis Pharmaceuticals Inc(APLS)COM03753U106$58.8M1,000,0001.7%
ANI Pharmaceuticals Inc(ANIP)COM00182C103$56.8M822,0011.6%
Travere Therapeutics Inc(TVTX)COM89422G107$56.8M7,370,0001.6%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$51.3M3,187,4151.5%
Kymera Therapeutics Inc(KYMR)COM501575104$50.7M1,262,2461.5%
Invivyd Inc(IVVD)COM00534A102$48.6M10,953,9371.4%
Spyre Therapeutics Inc(SYRE)COM NEW00773J202$46.0M1,213,4201.3%
Nurix Therapeutics Inc(NRIX)COM67080M103$44.1M2,997,8301.3%
Hillevax IncCOM43157M102$42.8M2,572,4601.2%
Editas Medicine Inc(EDIT)COM28106W103$41.0M5,527,2901.2%
Fate Therapeutics Inc(FATE)COM31189P102$40.9M5,572,6071.2%
Terns Pharmaceuticals Inc(TERN)COM880881107$40.0M6,100,0001.1%
Engene Holdings Inc(ENGN)COM29286M105$38.1M2,250,0001.1%
Tourmaline BIO Inc(TRML)COM89157D105$36.5M1,595,4001.0%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$36.5M3,225,4191.0%
Silence Therapeutics PLC(SLN)ADS82686Q101$35.5M1,643,8811.0%
Pacific Biosciences Calif in(PACB)COM69404D108$26.3M7,000,0000.8%
Cybin Inc(CYBNEUR)COM23256X100$24.0M58,139,5350.7%
Alector Inc(ALEC)COM014442107$22.7M3,769,3860.7%
Nuvalent Inc(NUVL)COM670703107$20.6M274,5120.6%
Agenus Inc(AGENEUR)COM NEW00847G705$18.4M31,697,5390.5%
Pyxis Oncology Inc(PYXS)COMMON STOCK747324101$17.8M4,184,1000.5%
Nektar Therapeutics(NKTREUR)COM640268108$17.2M18,400,0000.5%
Immunovant Inc(IMVT)COM45258J102$15.9M493,3520.5%
Neumora Therapeutics Inc.(NMRA)COM640979100$13.8M1,000,0000.4%
Repare Therapeutics Inc(RPTX)COM760273102$12.6M2,684,3440.4%
Intra-Cellular Therapies Inc(ITCIEUR)PutCOM46116X101$12.1M175,4000.3%
Page 1 of 2Next